This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (35)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Bernard S. Bloom, PhD; David J. Wierz, MA; Mark V. Pauly, PhD

JAMA. 1986;256(18):2523-2530.

Abstract
Substituting generic for brand drugs has been increasing for two decades with the expectation that it leads to important savings. We studied 891 862 prescriptions, written for 21 pairs of branded and generic drugs, dispensed between April 1, 1984, and June 30, 1984, by 1363 selected pharmacies in 39 states. The cost per pill paid by the pharmacy was always less for the generic than the branded drug. The price per pill paid by the consumer was usually less for the generic than the brand. The wide and skewed distribution of consumer prices within and among pharmacies means that consumers cannot be guaranteed the lowest cost simply by buying generic drugs. The probability that generic would be less expensive than brand varied widely across drug pairs from.33 to.99. Continued search is no guarantee that the full distribution of prices or the lowest or nearly-lowest price will be found.

(JAMA 1986;256:2523-2530)

Author Affiliations
From the Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia (Drs Bloom and Pauly); and Pennsylvania Blue Shield, Camp Hill, Pa (Mr Wierz). Mr Wierz is now with MEDCO Group, Fair Lawn, NJ

Footnotes
Reprint requests to University of Pennsylvania, 231 NEB-420 Service Dr, Philadelphia, PA 19104-6020 (Dr Bloom).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Cost Analysis of Topical Drug Regimens for Dermatophyte Infections
Chren and Landefeld
JAMA 1994;272:1922-1925.
ABSTRACT  

A Plea for Prices in Physician Prescribing
Reidenberg and Hodi
JAMA 1991;266:3285-3285.
ABSTRACT  

Can Physician Education Lower the Cost of Prescription Drugs? A Prospective, Controlled Trial
Frazier et al.
ANN INTERN MED 1991;115:116-121.
ABSTRACT  

Cost-Benefit Issues in the Practice of Internal Medicine
Friedman and Katt
Arch Intern Med 1991;151:1165-1168.
ABSTRACT  

Cutting Into Cholesterol: Cost-effective AlternatiCost-effective Treating Hypercholesterolemia
Kinosian and Eisenberg
JAMA 1988;259:2249-2254.
ABSTRACT  

The Economics of Generic Prescribing: Winners and Losers
Lasagna
JAMA 1986;256:2566-2566.
ABSTRACT